SCHAUMBURG, Ill., April 24, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the 2013 first quarter pre-market on Monday, May 6, 2013 and will host a teleconference and webcast at 9 a.m. ET to review the results. Interested parties may access the live call by dialing: Within the United States: 877-293-5456 International: 707-287-9357 A live webcast of the teleconference will be available on the company's website at: http://investor.sagentpharma.com/events.cfm . A replay of the presentation will be available on the Sagent website or by dialing: Toll-Free: 855-859-2056 Passcode: 43662748 The replay will be available until May 20, 2013. About Sagent Pharmaceuticals Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.
CONTACT: SAGENT CONTACT: Jonathon Singer email@example.com (847) 908-1605